Rahul Singhvi
M.S. and Sc.D. degrees in chemical engineering from MIT. MBA from the Wharton School of the University of Pennsylvania, where he graduated as a Palmer Scholar.
- Global leader in the Life Sciences industry and is cofounder of the biomanufacturing company, Resilience (National Resilience, Inc.).
- Former Operating Partner at Flagship Pioneering, where he founded and operated companies launched from Flagship’s innovation foundry, Flagship labs.
- Former Chief Operating Officer of Takeda’s Vaccine Business Unit where he led worldwide vaccine CMC manufacturing.
- Former President and CEO of Novavax, Inc. where he transformed the company from a specialty pharmaceutical business into a vaccine development company.
- Career began at Merck & Co in 1994, where he held several positions in R&D and manufacturing.
- Serves on the Board of Trustees of the Keck Graduate Institute, and on the Board of Directors for Codexis (Nasdaq:CDXS), and Garuda Therapeutics (private)
